Technology | 2009.06.25
OraSure Technologies Provides Update on Clinical Development Programs and OraQuick Manufacturing
BETHLEHEM, Pa.--(BUSINESS WIRE)--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced an update regarding the status of its application for U.S. Food and Drug Administration (“FDA”) approval of an
For more information, please visit
http://www.businesswire.com/news/home/20090625005168/en
